0001178913-22-004054.txt : 20221115 0001178913-22-004054.hdr.sgml : 20221115 20221115161324 ACCESSION NUMBER: 0001178913-22-004054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221111 FILED AS OF DATE: 20221115 DATE AS OF CHANGE: 20221115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yaacov-Garbeli Dana CENTRAL INDEX KEY: 0001909822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38556 FILM NUMBER: 221391315 MAIL ADDRESS: STREET 1: KIRYAT HADASSAH STREET 2: MINRAV BUILDING, FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entera Bio Ltd. CENTRAL INDEX KEY: 0001638097 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 BUSINESS PHONE: 972-2-532-7151 MAIL ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 4 1 zk2228766.xml X0306 4 2022-11-11 0 0001638097 Entera Bio Ltd. ENTX 0001909822 Yaacov-Garbeli Dana KIRYAT HADASSAH MINRAV BUILDING, 5TH FLOOR JERUSALEM L3 9112002 ISRAEL 0 1 0 0 Chief Financial Officer Ordinary Shares, par value NIS 0.0000769 per share 2022-11-11 4 P 0 30000 0.52 A 30000 I By A2Z Counseling Ltd. Ordinary Shares, par value NIS 0.0000769 per share 2022-11-14 4 P 0 26580 0.536 A 56580 I By A2Z Counseling Ltd. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.50 to $0.54, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned by A2Z Counseling Ltd. of which the Reporting Person's owns a 33.33% interest and has effective control over voting and disposition of the shares. The Reporting Person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.53 to $0.54, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Dana Yaacov-Garbeli 2022-11-15